Clinical Trials & Research Participation
Clinical Trials & Research Participation
Live Search on ClinicalTrials.gov
Click your patient’s suspected diagnosis below to see all active trials worldwide (automatically filtered and kept up-to-date):
Currently Recruiting Trials (Highlights – updated Dec 2025)
Below are some of the most important actively recruiting studies (click title for full details on ClinicalTrials.gov):
ATH-1017 for PSP (Phase 2/3)
Sponsor: Athira Pharma | Phase: 2/3 | Sites: US, Europe, Australia | Recruiting
BIIB122 (DNL151) Extension Study – DLB/PD
Sponsor: Denali/Biogen | Phase: 2b extension | Multiple countries | Recruiting
This list is manually curated and updated monthly. Always verify current status on ClinicalTrials.gov.
How to Refer a Patient (for Physicians)
- Confirm the patient meets basic eligibility (e.g., probable PSP, MSA, CBD, DLB diagnosis).
- Click the relevant disease button above → filter for “Recruiting” on ClinicalTrials.gov.
- Select the trial → note NCT number and principal investigator/site.
- Contact the site coordinator directly (phone/email listed on the trial page) or use the “Contact” form on ClinicalTrials.gov.
- Send relevant records (MRI report, neurology notes, current medication list).
- Most sites respond within 48–72 hours for screening.
No central referral portal is required — direct site contact is fastest.
Dedicated Trial Coordinator Contacts
(Only displayed when sponsors explicitly permit public listing)
Currently no sponsor has authorised direct public coordinator details on this site.
Please use the individual trial’s contact form on ClinicalTrials.gov — sites are highly responsive.
Please use the individual trial’s contact form on ClinicalTrials.gov — sites are highly responsive.
Donate